ASTRO 2025 Annual Meeting Press Kit

The 2025 ASTRO Annual Meeting – the leading global conference in radiation oncology – will be held at San Francisco’s Moscone Center from September 27 to October 1. Led by ASTRO President Sameer Keole, MD, FASTRO, the meeting is organized around the theme, “Rediscovering Radiation Medicine and Exploring New Indications.” More than 2,500 abstracts, presented alongside educational panels, keynote addresses and other special programming, will explore the latest updates in radiation oncology, clinical trials results and patient care improvements. For additional details, view our media advisory and find schedule and presenter details in the Annual Meeting portal.

News Briefings

ASTRO news briefings will spotlight noteworthy and high-impact research presented at the meeting. Briefings will be held in room 105 of the Moscone Center, with live webcasts for offsite reporters.

Monday, September 29, 11:00 a.m. Pacific time (2:00 p.m. Eastern)

• A double-blinded placebo-controlled biomarker stratified randomized trial of apalutamide (APA) and radiotherapy for recurrent prostate cancer (NRG GU006, BALANCE trial) (LBA 04), presented by Daniel Spratt, MD

• Clinical effectiveness of single course low-dose radiation therapy in knee osteoarthritis: Short-term results from the randomized, sham-controlled trial (LBA 06), presented by Byoung Hyuck Kim, MD, PhD

• Bladder Adjuvant RadioTherapy (BART): Clinical outcomes from a phase III multicenter randomized controlled trial (Abstract 2), presented by Vedang Murthy, MD

• ¹⁷⁷Lutetium-PSMA neoadjuvant to ablative radiotherapy for oligorecurrent prostate cancer: Primary endpoint analysis of the phase II LUNAR randomized trial (Abstract 3), presented by Amar Kishan, MD, PhD

• Stereotactic arrhythmia radiotherapy (STAR) vs. repeat catheter ablation for high-risk refractory ventricular tachycardia: 3-year safety and efficacy outcomes (Abstract 247), presented by Shannon Jiang, MD

• Moderated by Catheryn Yashar, MD, FASTRO, incoming ASTRO President-elect

• Register for the Monday briefing here.

Tuesday, September 30, 8:00 a.m. Pacific time (11:00 a.m. Eastern)

• Phase III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: A radiotherapy comparative effectiveness (RADCOMP) consortium trial: Health-related quality of life outcomes (LBA 01), presented by Shannon MacDonald, MD, FASTRO

• Primary results for the phase III trial of toxicity reduction using proton beam therapy for oropharyngeal cancer (TORPEdO; CRUK/18/010) (LBA 02), presented by David Thomson, MD

• Primary results from NRG-GU005: A phase III trial of SBRT vs. hypofractionated IMRT for localized intermediate risk prostate cancer (Abstract 1), presented by Rodney Ellis, MD

• Ten-year outcomes of the revised STARS trial comparing radiation and surgery for early-stage non-small cell lung cancer (Abstract 268), presented by Joe Chang, MD, PhD, FASTRO

• Moderated by Kenneth Rosenzweig, MD, FASTRO, Chair of the ASTRO Annual Meeting Scientific Committee

• Register for the Tuesday briefing here.

Press Registration

ASTRO provides complimentary meeting registration to credentialed news professionals representing media organizations for the express purpose of gathering news and information to produce editorial coverage of the ASTRO Annual Meeting. Read more about eligibility for press registration.

• Submit your press registration.

ASTRO will host an on-site press office in room 104 of the Moscone Center for reporters covering the meeting in person.

Embargo Policy and Access to Abstracts

All abstracts to be presented at the ASTRO Annual Meeting are embargoed until 5:00 p.m. Eastern time on Friday, September 26, 2025. For more details, view the full embargo policy. Contact ASTRO's media relations team with questions about the embargo policy or for press access to embargoed materials.

Abstracts will be available online via the Annual Meeting Portal when the embargo lifts. Abstracts also will be published and available at that time in the International Journal of Radiation Oncology • Biology • Physics (Red Journal).

For More Information

• Visit the Annual Meeting Portal (abstracts, disclosures, schedule) or ASTRO 2025 microsite (general meeting info).

• View our PR Policies for Industry Partners.

• Connect with us on social media.

• Find patient information at RTAnswers.org.

• Contact ASTRO’s media relations team.